DEUTSCHE BANK AG\ - EMERGENT BIOSOLUTIONS INC ownership

EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 340 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of EMERGENT BIOSOLUTIONS INC
ValueSharesWeighting
Q3 2023$82,484
-95.8%
24,260
-90.9%
0.00%
-100.0%
Q2 2023$1,949,690
-32.4%
265,264
-4.7%
0.00%
-50.0%
Q1 2023$2,885,115
-10.6%
278,486
+1.9%
0.00%0.0%
Q4 2022$3,227,803
-61.4%
273,311
-31.4%
0.00%
-60.0%
Q3 2022$8,367,000
-33.2%
398,593
-1.2%
0.01%
-28.6%
Q2 2022$12,525,000
-19.9%
403,528
+5.9%
0.01%0.0%
Q1 2022$15,643,000
+161.0%
381,000
+176.3%
0.01%
+133.3%
Q4 2021$5,994,000
-9.6%
137,885
+4.2%
0.00%0.0%
Q3 2021$6,629,000
-21.0%
132,384
-0.6%
0.00%
-25.0%
Q2 2021$8,388,000
-52.6%
133,169
-30.1%
0.00%
-60.0%
Q1 2021$17,709,000
-17.1%
190,604
-20.0%
0.01%
-23.1%
Q4 2020$21,359,000
+12.6%
238,392
+29.8%
0.01%0.0%
Q3 2020$18,975,000
+11.2%
183,633
-14.9%
0.01%0.0%
Q2 2020$17,061,000
+30.3%
215,734
-4.7%
0.01%
+8.3%
Q1 2020$13,095,000
-3.1%
226,335
-9.7%
0.01%
+33.3%
Q4 2019$13,514,000
+42.6%
250,520
+38.1%
0.01%
+28.6%
Q3 2019$9,480,000
+64.7%
181,377
+52.1%
0.01%
+133.3%
Q2 2019$5,757,000
-54.7%
119,239
-52.7%
0.00%
-62.5%
Q1 2019$12,722,000
+116.9%
251,888
+154.5%
0.01%
+100.0%
Q4 2018$5,865,000
-79.1%
98,974
-76.8%
0.00%
-50.0%
Q3 2018$28,104,000
+10.7%
426,960
-15.1%
0.01%
+14.3%
Q2 2018$25,390,000
+31.9%
502,914
+37.6%
0.01%
-22.2%
Q1 2018$19,247,000
+63.1%
365,607
+43.9%
0.01%
+12.5%
Q4 2017$11,800,000
+70.1%
254,001
+48.1%
0.01%
+60.0%
Q3 2017$6,936,000
+185.2%
171,547
+139.0%
0.01%
+150.0%
Q2 2017$2,432,000
+78.0%
71,773
+52.4%
0.00%
+100.0%
Q1 2017$1,366,000
-16.4%
47,094
-5.5%
0.00%0.0%
Q4 2016$1,634,000
-61.6%
49,810
-63.1%
0.00%
-66.7%
Q3 2016$4,256,000
+26.9%
135,054
+13.1%
0.00%
+50.0%
Q2 2016$3,355,000
-19.7%
119,410
+3.9%
0.00%
-33.3%
Q1 2016$4,176,000
-59.7%
114,951
-55.6%
0.00%
-57.1%
Q4 2015$10,364,000
+123.0%
259,110
+58.8%
0.01%
+75.0%
Q3 2015$4,647,000
+18.6%
163,190
+37.2%
0.00%
+33.3%
Q2 2015$3,918,000
+41.2%
118,955
+23.2%
0.00%
+50.0%
Q1 2015$2,775,000
+20.9%
96,555
+14.5%
0.00%
+100.0%
Q4 2014$2,295,000
+71.0%
84,322
+33.8%
0.00%0.0%
Q3 2014$1,342,000
+23.3%
63,041
+30.0%
0.00%0.0%
Q2 2014$1,088,000
-57.0%
48,511
-51.6%
0.00%
-50.0%
Q1 2014$2,533,000
+14.7%
100,310
+4.3%
0.00%0.0%
Q4 2013$2,208,000
-6.0%
96,152
-22.1%
0.00%0.0%
Q3 2013$2,350,000123,4880.00%
Other shareholders
EMERGENT BIOSOLUTIONS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Zebra Capital Management LLC 22,111$908,0002.08%
Global Alpha Capital Management Ltd. 460,530$18,909,0001.62%
AIMZ Investment Advisors, LLC 70,625$2,900,0001.19%
Bridge City Capital, LLC 39,835$1,636,0000.76%
PALISADE CAPITAL MANAGEMENT, LP 560,409$23,010,0000.53%
EARNEST PARTNERS LLC 2,071,376$85,051,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 302,721$12,430,0000.50%
SummerHaven Investment Management, LLC 14,476$594,0000.34%
Ridgewood Investments LLC 10,004$411,0000.27%
AtonRa Partners 11,505$472,0000.26%
View complete list of EMERGENT BIOSOLUTIONS INC shareholders